U.S. Transportation Stock News

X4 Pharmaceuticals (XFOR) just posted its FY 2025 numbers with third quarter revenue of US$1.8 million, Basic EPS of US$0.69 loss, and a net loss of US$29.8 million, while trailing 12 month revenue stood at US$34.0 million with Basic EPS of US$5.90 loss and a net loss of US$95.1 million. Over the past few reported quarters, revenue has moved from US$0.6 million in the second quarter of 2024 to US$28.8 million in the first quarter of 2025, alongside EPS that swung from US$13.60 to US$0.04 and...

Recent share performance in context NVIDIA (NVDA) has seen mixed share performance recently, with a 1 day return of about a 0.7% decline and a 7 day move of roughly a 1.5% decline, while the past 3 months show a 6.4% gain. See our latest analysis for NVIDIA. While the recent 1 day and 7 day share price returns have been slightly negative and the year to date share price return is also lower, the 1 year total shareholder return of 57.66% and very large 3 and 5 year total shareholder returns...

Host Hotels & Resorts has completed the sale of the 444-room Four Seasons Resort Orlando at Walt Disney World Resort and the 125-room Four Seasons Resort and Residences Jackson Hole for US$1.10 billion, realizing an 11.0% unlevered IRR and an EBITDA multiple well above its recent trading level. The transaction marks a major capital recycling move that management says will bolster the balance sheet and expand financial flexibility to pursue higher-return opportunities and future...

Event context and recent stock moves Quest Diagnostics (DGX) shares recently traded around $198.61, with the stock showing a 0.2% decline over the past day and a 1.1% decline over the past week, while remaining higher over the past 3 months. See our latest analysis for Quest Diagnostics. While the share price has seen a 4.0% decline over the past month, momentum over a longer horizon remains positive, with a 10.9% 3 month share price return and a 17.3% 1 year total shareholder return...

NANO Nuclear Energy Inc. recently reported past progress in developing an optimized High-Assay Low-Enriched Uranium (HALEU) transportation system, leveraging an exclusive Idaho National Laboratory basket and cask design and technical support from nuclear logistics specialist GNS. The project’s early engineering milestones and planned Nuclear Regulatory Commission certification process highlight NANO Nuclear’s push to build a vertically integrated role in the advanced nuclear fuel supply...

A U.S. appeals court recently overturned a US$481 million patent infringement award that Columbia University had previously secured against Gen Digital, sending the case back to a Virginia federal court to reassess whether the cybersecurity-related patents cover abstract ideas. This legal shift meaningfully reduces immediate financial overhang for Gen Digital and could reshape how the company manages intellectual property risk and litigation exposure. We will now explore how this removal of...

Silvercrest Asset Management Group (SAMG) has reported third quarter FY 2025 revenue of US$31.3 million and basic EPS of US$0.07, with trailing 12 month revenue at US$125.3 million and EPS at US$0.73 providing the broader earnings backdrop. Over recent periods, revenue has moved between US$30.4 million and US$31.4 million per quarter, while quarterly EPS has ranged from US$0.07 to US$0.28. This gives investors a clearer view of how the income statement has evolved into the current trailing 12...

Natural Gas Services Group's FY 2025 Earnings Snapshot Natural Gas Services Group (NGS) has reported its FY 2025 results with third quarter revenue of US$43.4 million and basic EPS of US$0.46, alongside trailing twelve month revenue of US$166.8 million and EPS of US$1.49 that frame the scale of the current earnings run rate. Over recent periods the company has seen revenue move from US$38.5 million in Q2 2024 to US$43.4 million in Q3 2025, while quarterly EPS has ranged from US$0.23 in Q4...

Orange County Bancorp (OBT) has just wrapped up FY 2025 with fourth quarter total revenue of US$31.5 million, basic EPS of US$0.93 and net income of US$12.4 million. This sets the tone for how investors will read the full year against recent momentum in the share price around US$31.40. The company has seen revenue move from US$27.4 million and EPS of US$0.63 in Q4 2024 to US$31.5 million and EPS of US$0.93 in Q4 2025. Trailing twelve month figures sit at US$119.5 million of revenue and EPS of...

In recent remarks, Hamilton Lane argued that private credit is not in a bubble, contending that banks hold riskier loan pools and that private credit losses should compare favorably with bank and broadly syndicated loan exposures. The firm also signaled that private credit fundraising is likely to be concentrated among a handful of very large managers, underscoring the growing importance of scale in this corner of the alternatives market. We’ll now examine how Hamilton Lane’s confidence in...

Latest FY 2025 Results Set the Tone for BingEx (FLX) BingEx (FLX) has put fresh FY 2025 numbers on the table, with Q3 revenue of C¥1,005.4 million and basic EPS of C¥0.63 framing a quarter that sits between a weak start to the year and a stronger Q2 print. The company has seen quarterly revenue move from C¥960.8 million in Q1 2025 to C¥1,024.6 million in Q2 and then C¥1,005.4 million in Q3, while basic EPS has swung from a loss of C¥0.15 in Q1 to C¥0.77 in Q2 and C¥0.63 in Q3. This gives...

Constellation Brands recently reported Q3 2026 earnings ahead of expectations, with its beer segment benefiting from pricing actions and cost savings while overall revenue declined. The company’s ability to sustain a beer operating margin around 38.0% amid revenue pressure and macro headwinds highlights the resilience of brands like Modelo Especial, Pacifico, and Victoria. Next, we’ll examine how maintaining strong beer margins despite cost pressures could influence Constellation Brands’...

Xenon Pharmaceuticals (XENE) has drawn fresh attention after reporting positive Phase 3 X TOLE2 results for azetukalner in focal onset seizures, followed closely by a US$650 million follow on equity offering. See our latest analysis for Xenon Pharmaceuticals. The latest clinical success and equity raise come after a strong run, with a 30 day share price return of 33.08% and a 1 year total shareholder return of 56.95%. This suggests momentum has been building around Xenon Pharmaceuticals as...

Event context and recent share performance Trinity Capital (TRIN) has drawn attention after a recent move in its share price, with the stock up about 2.9% over the past day but down over the past week and month. See our latest analysis for Trinity Capital. That 2.9% one day share price gain comes after weaker short term momentum, with 7 day, 30 day and 90 day share price returns all in negative territory, while longer term total shareholder returns over 1, 3 and 5 years have been positive. If...

Playboy (PLBY) has just posted a small profit for Q3 2025, with revenue of US$29.0 million and net income of US$0.46 million translating to basic EPS of US$0.00 when rounded, a marked contrast to prior quarterly losses. Over recent periods the company has seen quarterly revenue move in a tight band around the high US$20 million level, with basic EPS running from a loss of US$0.45 in Q3 2024 to a loss of US$0.10 in Q1 2025 before this latest positive print. This sets up a results season where...

In recent days, Bloom Energy announced that Brookfield Asset Management agreed to invest up to US$5.00 billion to deploy Bloom’s fuel cell technology in data centers, against a backdrop of heightened interest in alternative power solutions amid rising oil prices and geopolitical tension. This large capital commitment, combined with growing demand from AI-driven data centers and broader on-site power applications, highlights Bloom’s increasing relevance as a provider of resilient local power...

Getty Images Holdings (GETY) has just closed out FY 2025 with fourth quarter revenue of US$282.3 million and a basic EPS loss of US$0.22, alongside trailing twelve month revenue of US$981.3 million and a trailing EPS loss of US$0.50. Over the past year, the company has seen quarterly revenue range from US$224.1 million to US$282.3 million, with EPS swinging between a profit of US$0.05 in Q3 2025 and losses of up to US$0.25 in Q1 2025. During the same period, trailing net income moved from a...

Primis Financial's FY 2025 Earnings Snapshot Primis Financial (FRST) closed FY 2025 with fourth quarter revenue of US$78.4 million and basic EPS of US$1.20, while trailing twelve month revenue reached US$211.3 million and EPS came in at US$2.49. Over recent periods, revenue has moved from US$5.8 million in Q4 2024 to US$78.4 million in Q4 2025, and basic EPS has shifted from a loss of US$0.94 per share in Q4 2024 to EPS of US$1.20, putting margins and profitability under closer scrutiny for...

Sempra recently completed a fixed-income offering, issuing US$800 million of 5.25% senior unsecured notes due March 15, 2036, at a slight discount to face value. This sizable, callable bond issue could reshape Sempra’s capital structure and funding flexibility, influencing how it finances future infrastructure and LNG projects. We’ll now examine how raising nearly US$800 million in new senior unsecured debt may influence Sempra’s existing investment narrative and risk profile. Invest in the...

Bicycle Therapeutics (BCYC) has just posted its FY 2025 third quarter numbers, with revenue of about US$11.7 million and a basic EPS loss of US$0.85. Trailing twelve month figures show revenue of roughly US$28.3 million and a basic EPS loss of US$3.62. Over recent quarters, revenue has ranged from US$2.9 million to US$11.7 million, while quarterly basic EPS losses have moved between US$0.74 and US$1.14. This gives investors a clearer sense of a business that appears to be in investment mode...

Establishment Labs Holdings recently reported strong 2025 operating performance, highlighting rapid adoption of its Motiva implant platform, progress with next‑generation Preservé and Mia procedures, and new international partnerships including China under the leadership of CEO Peter Caldini. This combination of product innovation and efforts to streamline global distribution, particularly in a large regulatory market like China, could materially influence the company’s long-term growth...

RF Industries (RFIL) just wrapped up FY 2025 with fourth quarter revenue of US$22.7 million and basic EPS of US$0.02, alongside trailing 12 month revenue of US$80.6 million and basic EPS of essentially breakeven at US$0.01. Over recent quarters the company has seen revenue move from US$16.8 million in Q3 2024 to US$18.5 million in Q4 2024 and then to US$22.7 million in Q4 2025. Quarterly EPS shifted from a loss of US$0.07 in Q3 2024 to a loss of US$0.02 in Q4 2024 and then to a profit of...

Cango (NYSE:CANG) has released its FY 2025 figures, with Q3 showing total revenue of US$224.6 million and basic EPS of US$0.11, compared with a trailing twelve month picture that includes total revenue of US$621.6 million and a basic EPS loss of US$0.52. Over recent periods, the company has reported quarterly revenue ranging from RMB3.8 million to RMB145.2 million and basic EPS moving between a loss of RMB0.14 and a profit of RMB0.06. This gives investors a broad range of outcomes to consider...

Greystone Housing Impact Investors FY 2025 Earnings Snapshot Greystone Housing Impact Investors (GHI) has just posted its FY 2025 third quarter numbers, with total revenue of about US$8.0 million and basic EPS of US$0.03, set against trailing twelve month EPS of US$0.17 on revenue of roughly US$26.2 million. The company’s quarterly revenue has moved from US$7.1 million in FY 2024 Q2 to US$9.1 million in Q3, then US$6.8 million in Q4, and on to US$11.2 million, US$0.3 million and US$8.0...